OmniComm Systems® and Bio-Optronics® Provide CTMS and EDC, Real Time Data Access to Top-Tier Children’s Cancer Research Institution

ROCHESTER, NY, UNITED STATES - Mar 2, 2017 - Bio-Optronics Inc., a leading software and services solutions provider to the healthcare and life sciences industry announced they are teaming up with OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology. Under the agreement, the two companies will integrate OmniComm TrialMaster® EDC with Bio-Optronics Clinical Conductor® clinical trial management system (CTMS) for multiple facilities at a major institution seeking to develop cures and treatments for cancer and other catastrophic diseases.

This multi-center children cancer research organization is looking to increase productivity and efficiency while reducing costs. This requires the integration of CTMS and electronic data capture (EDC) systems. Integrating these systems ensures that overlapping data is reported correctly in both systems, saving time and reducing the opportunity for errors. For most organizations, redundant data entry is a major source of operational inefficiency and errors.

EDC is typically the primary data source to recognize fundamental clinical metrics such as patient accrual, open query counts, and even reports adverse experiences. CTMS serves as the operational hub for a clinical trial, tracking and reporting on numerous components of a study, including study progress, completed visits, enrollment, financial activity, and regulatory compliance. The integration between EDC and CTMS allow individuals responsible for clinical operations to more proactively manage activities such as site initiation, patient recruitment, patient safety, site payments, capacity planning, and risk based monitoring.

“Bio-Optronics’ Clinical Conductor has proven to be an excellent complement to TrialMaster because of its dual focus on sponsor and site clinical trial management,” states Ken Light, EVP of Operations, OmniComm Systems. “Bio-Optronics has incorporated attention to details that allow sponsors and sites to configure, drill down, and report on the key operational criteria that document clinical activities, drive uniform processes, and support operational change. The Bio-Optronics team has been very impressive to work with, and the technology is fully compatible with OmniComm’s Microsoft-based technology stack.”

Integrating OmniComm TrialMaster EDC and Bio-Optronics’ Clinical Conductor enables data to synchronize in real time upon data entry. This constant communication ensures all parties are operating with the most current information.

“This co-venture exemplifies the impact of integrating best-in-class research applications from organizations with specific areas of expertise,” says Steve Bailey, VP of Clinical Conductor CTMS at Bio-Optronics. “OmniComm’s TrialMaster© EDC delivers the robust tools and insights that pair with Clinical Conductor to deliver the most complete end-to-end research management solution in the marketplace, and we look forward to building the relationship between our two companies and delivering value to the marketplace.”

About Bio-Optronics Inc.

Bio-Optronics, the creator of Clinical Conductor CTMS, is a leading software and services company that creates user-focused software and services for healthcare organizations that positively impacts the lives of patients around the world. Clinical Conductor CTMS is an established clinical trial management system, utilized by thousands of research organizations worldwide, designed to simplify and standardize complex research processes for businesses managing and conducting clinical trials. For more information, visit www.bio-optronics.com.

About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,800 clinical trials. For more information, visit www.omnicomm.com.

Trademarks
Bio-Optronics and Clinical Conductor are registered trademarks of Bio-Optronics, Inc. OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.